Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05430191 · ClinicalTrials.gov registry record
Equitable Implementation of Cascade Screening for Familial Hypercholesterolemia
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 22
- Enrollment target
NCT05430191 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 22 participants.
The verdict
NCT05430191 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
Design, refine, and pilot the two implementation approaches using behavioral economics and then seek further feedback prior to the proposed clinical trial, consistent with these recommendations. Aim 1. Co-design both implementation strategies using behavioral economics in partnership with the Family Heart Foundation and key partners from diverse backgrounds. Aim 2. Pilot strategies with 20 patients with high cholesterol and/or with familial hypercholesterolemia (FH) to ascertain feasibility, acceptability, appropriateness.
Interventions
- OTHER Cascade Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2022-07-20 |
| Est. Completion | 2023-06-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05430191
The ClinicalTrials.gov registry entry for NCT05430191 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cascade Screening is the first listed.
NCT05430191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05430191 about?
NCT05430191 is a clinical study titled "Equitable Implementation of Cascade Screening for Familial Hypercholesterolemia". Design, refine, and pilot the two implementation approaches using behavioral economics and then seek further feedback prior to the proposed clinical trial, consistent with these recommendations. Aim 1. Co-design both implementation strategies using behavioral economics in partnership with the Famil...
What is the current status of trial NCT05430191?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2022-07-20. Estimated completion is 2023-06-20.
What interventions are being tested in trial NCT05430191?
The interventions under investigation include: Cascade Screening (OTHER).
Who is sponsoring clinical trial NCT05430191?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.